...

首页> 外文期刊>Oncology research and treatment. >European Commission grants Approval Extension for Blincyto (R) (Blinatumomab) for adult patients with Philadelphia Chromosome negative B-cell Progenitor of acute lymphoblastic Leukemia with minimal Residual Disease

【24h】

European Commission grants Approval Extension for Blincyto (R) (Blinatumomab) for adult patients with Philadelphia Chromosome negative B-cell Progenitor of acute lymphoblastic Leukemia with minimal Residual Disease

机译：欧盟委员会为Blincyto（Blinatumomab）的批准扩展为成年患者的费城染色体阴性B细胞祖细胞急性淋巴细胞白血病，残留疾病最少

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2019年第3期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. European Commission grants Approval Extension for Blincyto (R) (Blinatumomab) for adult patients with Philadelphia Chromosome negative B-cell Progenitor of acute lymphoblastic Leukemia with minimal Residual Disease [J] . Oncology research and treatment. . 2019,第3期

机译：欧盟委员会为Blincyto（Blinatumomab）的批准扩展为成年患者的费城染色体阴性B细胞祖细胞急性淋巴细胞白血病，残留疾病最少
2. Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT [J] . Bone marrow transplantation . 2020,第7期

机译：减少强度调节是费城染色体阳性急性淋巴细胞白血病的合理替代品，这些老年患者均取得负少残留疾病的老年患者：JSHCT成人急性淋巴细胞白血病工作组的报告
3. Disease Burden Subgroup Analysis of HealthRelated Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study ( TOWER) [J] . Stein Anthony S., Zimmerman Zachary F., Cannell Paul, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：疾病负担亚群分析Blinatumomab的健康生活质量与患者的复发或难治性费城染色体阴性B细胞前体急性淋巴细胞白血病在随机开放标签第3研究（塔）
4. Discrimination of minimal residual disease in acute lymphoblastic leukemia by using single-beam acoustic tweezer [C] . Hsiao-Cliuan Liu, Hye Na Kim, Enzi Jiang, IEEE International Ultrasonics Symposium . 2017

机译：用单束声镊鉴别急性淋巴细胞白血病的最小残留病
5. Prognostic factors in patients with Philadelphia chromosome positive acute lymphoblastic leukemia. [D] . Faccuseh, Maria. 1999

机译：费城染色体阳性的急性淋巴细胞白血病患者的预后因素。
6. Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia [O] . Mingming Zhang, Huarui Fu, Xiaoyu Lai, -1

机译：首次完全缓解后实现的最小残留疾病可预测费城染色体阴性急性淋巴细胞白血病成人患者的结果。
7. Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia. [O] . Mingming Zhang, Huarui Fu, Xiaoyu Lai, 2016

机译：完全缓解的首次实现的最小残留疾病预测费城染色体 - 阴性急性淋巴细胞白血病的成年患者的结果。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号